Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3

---

Yapici Z., Fan P. -., Lawson J. A., Belousova E., Gazri H. E., Ridolfi A., ...More

13th European Congress on Epileptology, Vienna, Austria, 26 - 30 August 2018, vol.59, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 59
• City: Vienna
• Country: Austria
• Istanbul University Affiliated: Yes